Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Weight Loss 1Polycystic Ovary Syndrome 1Metabolic Syndrome 1Insulin Resistance 1

Interventions

pembrolizumab 1251Specimen Handling 867Carboplatin 816Magnetic Resonance Spectroscopy 803Cyclophosphamide 794Cisplatin 715Nivolumab 646Paclitaxel 623Radiotherapy 564Gemcitabine 562Biopsy 529Bevacizumab 468Dexamethasone 433fludarabine 404Docetaxel 370venetoclax 365Oxaliplatin 362Fluorouracil 352Capecitabine 350atezolizumab 341Rituximab 326durvalumab 326Doxorubicin 313Radiosurgery 305Pemetrexed 302Drug Therapy 294Standard of Care 292Ipilimumab 289Etoposide 279Radiation 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Diet, Reducing × 1 year × Clear all
NCT07380841 2026-02-02

PCOS-COMBO (9)

Islamabad Medical and Dental College

Phase NA Completed
192 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Weight Loss, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡